Reduced AKT activity, frequently observed in MDD, has been linked to neuronal atrophy in the hippocampus and prefrontal cortex, impairing synaptic function by inhibiting the synthesis of synaptic proteins (e.g., PSD-95, Synapsin). This evidence concerns the gene AKT1 and major depressive disorder.